Molecular and genetic diversity in the metastatic process of melanoma

Journal of Pathology

Volumn 233, Issue 1, 2014, Pages 39-50

  Harbst, Katja ^a   Lauss, Martin ^a   Cirenajwis, Helena ^a   Winter, Christof ^a   Howlin, Jillian ^a   Törngren, Therese ^a   Kvist, Anders ^a   Nodin, Björn ^a   Olsson, Eleonor ^a   Häkkinen, Jari ^a   Jirström, Karin ^a   Staaf, Johan ^a   Lundgren, Lotta ^a,b   Olsson, Håkan ^a   Ingvar, Christian ^a   Gruvberger Saal, Sofia K ^a   Saal, Lao H ^a   Jönsson, Göran ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BRAF; deep sequencing; gene expression; melanoma; NRAS

Indexed keywords

ADULT; AGED; ARTICLE; BRAF GENE; CDH1 GENE; COPY NUMBER VARIATION; GENE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; MIDDLE AGED; MUTATIONAL ANALYSIS; ONCOGENE N RAS; PRIORITY JOURNAL; PTEN GENE; SOMATIC MUTATION; ULTRAVIOLET RADIATION; YOUNG ADULT;

BRAF; DEEP SEQUENCING; GENE EXPRESSION; MELANOMA; NRAS;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CHROMOSOMES, HUMAN; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; GTP PHOSPHOHYDROLASES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS B-RAF; PTEN PHOSPHOHYDROLASE; SKIN NEOPLASMS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84898597696     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4318     Document Type: Article

References (27)

1. Sosman JA, Kim KB, Schuchter L, et al., Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012; 366: 707-714.
2. Flaherty KT, Robert C, Hersey P, et al., Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 2012; 367: 107-114.
3. Wilmott JS, Tembe V, Howle JR, et al., Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine. Mol Cancer Ther 2012; 11: 2704-2708.
4. Colombino M, Capone M, Lissia A, et al., BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol 2012; 30: 2522-2529.
5. Nik-Zainal S, Alexandrov LB, Wedge DC, et al., Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149: 979-993.
6. Hodis E, Watson IR, Kryukov GV, et al., A landscape of driver mutations in melanoma. Cell 2012; 150: 251-263.
7. Krauthammer M, Kong Y, Ha BH, et al., Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006-1014.
8. Gerlinger M, Rowan AJ, Horswell S, et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-892.
9. Katona TM, Jones TD, Wang M, et al., Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol 2007; 31: 1029-1037. (Pubitemid 47012299)
10. Harbst K, Staaf J, Masback A, et al., Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Melanoma Res 2010; 20: 381-391.
11. Harbst K, Staaf J, Lauss M, et al., Molecular profiling reveals low- and high-grade forms of primary melanoma. Clin Cancer Res 2012; 18: 4026-4036.
12. Jonsson G, Busch C, Knappskog S, et al., Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res 2010; 16: 3356-3367.
13. Koboldt DC, Zhang Q, Larson DE, et al., VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22: 568-576.
14. Li J, Lupat R, Amarasinghe KC, et al., CONTRA: copy number analysis for targeted resequencing. Bioinformatics 2012; 28: 1307-1313.
15. Curtin JA, Fridlyand J, Kageshita T, et al., Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-2147. (Pubitemid 41653105)
16. Chen K, Wallis JW, McLellan MD, et al., BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 2009; 6: 677-681.
17. Popova T, Manie E, Stoppa-Lyonnet D, et al., Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol 2009; 10: R128.
18. Greenman C, Stephens P, Smith R, et al., Patterns of somatic mutation in human cancer genomes. Nature 2007; 446: 153-158. (Pubitemid 46398669)
19. Pfeifer GP, You YH, Besaratinia A,. Mutations induced by ultraviolet light. Mutat Res 2005; 571: 19-31. (Pubitemid 40313429)
20. Hoek KS, Schlegel NC, Brafford P, et al., Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006; 19: 290-302. (Pubitemid 44015592)
21. Widmer DS, Cheng PF, Eichhoff OM, et al., Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res 2012; 25: 343-353.
22. Eichhoff OM, Zipser MC, Xu M, et al., The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report. Melanoma Res 2010; 20: 349-355.
23. Berger MF, Hodis E, Heffernan TP, et al., Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012; 485: 502-506.
24. Marchesi F, Turriziani M, Tortorelli G, et al., Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol Res 2007; 56: 275-287. (Pubitemid 47488901)
25. Alexandrov LB, Nik-Zainal S, Wedge DC, et al., Signatures of mutational processes in human cancer. Nature 2013; 500: 415-421.
26. Muramatsu M, Kinoshita K, Fagarasan S, et al., Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553-563.
27. Lee H, Popodi E, Tang H, et al., Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. Proc Natl Acad Sci USA 2012; 109: E2774-2783.